NO874159L - Nye lymfokin-relaterte peptider. - Google Patents

Nye lymfokin-relaterte peptider.

Info

Publication number: NO874159L
Authority: NO; Norway
Prior art keywords: related peptides; new lymphokine; lymphokine; new; peptides
Prior art date: 1986-10-03

Application number

NO874159A

Other languages

English (en)

Other versions

NO874159D0 (no

Inventor

Karel Gerrit Odnik

Roger Clerec

Nico Cerletti

Josef Brueggen

Lajos Tarcsay

Clemens Sorg

Walter Wiesendanger

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-10-03

Filing date

1987-10-02

Publication date

1988-04-05

1986-10-03 Priority claimed from GB868623850A external-priority patent/GB8623850D0/en

1986-11-27 Priority claimed from GB868628358A external-priority patent/GB8628358D0/en

1987-10-02 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1987-10-02 Publication of NO874159D0 publication Critical patent/NO874159D0/no

1988-04-05 Publication of NO874159L publication Critical patent/NO874159L/no

1992-03-17 Priority to NO921024A priority Critical patent/NO921024D0/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/70—Vector systems having a special element relevant for transcription from fungi
- C12N2830/702—Vector systems having a special element relevant for transcription from fungi yeast

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Toxicology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)

NO874159A 1986-10-03 1987-10-02 Nye lymfokin-relaterte peptider. NO874159L (no)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO921024A NO921024D0 (no)	1986-10-03	1992-03-17	Nye lymfokin-relaterte peptider

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB868623850A GB8623850D0 (en)	1986-10-03	1986-10-03	Lymphokine related peptide
GB868628358A GB8628358D0 (en)	1986-11-27	1986-11-27	Lymphokine related peptides

Publications (2)

Publication Number	Publication Date
NO874159D0 NO874159D0 (no)	1987-10-02
NO874159L true NO874159L (no)	1988-04-05

Family

ID=26291377

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO874159A NO874159L (no)	1986-10-03	1987-10-02	Nye lymfokin-relaterte peptider.

Country Status (11)

Country	Link
US (2)	US5350687A (no)
EP (1)	EP0263072B1 (no)
JP (1)	JPH09188698A (no)
AU (1)	AU7930987A (no)
DE (1)	DE3789413T2 (no)
DK (1)	DK517787A (no)
ES (1)	ES2052602T3 (no)
FI (1)	FI874287A (no)
IE (1)	IE61773B1 (no)
NO (1)	NO874159L (no)
PT (1)	PT85849B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2750604B1 (fr) *	1996-07-02	2002-09-20	Oreal	Heteromere liant l'acide arachidonique et son utilisation en cosmetique ou pharmacie
WO1990011301A1 (en) *	1989-03-17	1990-10-04	Genetics Institute, Inc.	Human macrophage migration inhibitory factor
GB8915414D0 (en) *	1989-07-05	1989-08-23	Ciba Geigy	Novel cytokines
JP2747839B2 (ja) *	1989-08-14	1998-05-06	花王株式会社	モノクローナル抗体
US5149544A (en) *	1989-11-13	1992-09-22	Research Corporation Technologies, Inc.	Method of inhibiting progenitor cell proliferation
US5731166A (en) *	1990-09-05	1998-03-24	The Heart Research Institute Ltd.	Recombinant production of chemotactic CP-10 polypeptides and therapeutic methods using them
CH685959A5 (de) *	1992-08-24	1995-11-15	Biomedicals Ag	Diagnostische Testpackung zur Bestimmung von Proteinen.
US6030615A (en) *	1993-05-17	2000-02-29	The Picower Institute For Medical Research	Combination method for treating diseases caused by cytokine-mediated toxicity
US5776348A (en) *	1995-02-07	1998-07-07	Massachusetts Institute Of Technology	Mineral precipitation system and method for inhibiting mineral precipitate formation
EP0972022A2 (en)	1997-01-21	2000-01-19	Human Genome Sciences, Inc.	Polynucleotides and polypeptides encoding receptors
US6706683B1 (en)	1998-09-29	2004-03-16	Asahi Kasei Pharma Corporation	Method for controlling the release of granules
DE69941627D1 (de) *	1998-11-05	2009-12-17	Univ Michigan	Für krebs
UY27304A1 (es)	2001-05-24	2002-12-31	Avanir Pharmaceuticals	Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
AU2003212246A1 (en) *	2002-02-15	2003-09-04	Johannes Roth	Method for diagnosis of inflammatory diseases using mrp8/mrp14
WO2004004770A1 (en) *	2002-07-05	2004-01-15	Universite Laval	Chemotactic factor inhibitor for modulating inflammatory reactions
TW200418829A (en)	2003-02-14	2004-10-01	Avanir Pharmaceutics	Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
US7361474B2 (en) *	2003-02-24	2008-04-22	United States Of America As Represented By The Department Of Veterans Affairs	Serum macrophage migration inhibitory factor (MIF) as marker for prostate cancer
EP1608397B1 (en)	2003-03-28	2008-10-15	Universite Laval	S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
BRPI0413695A (pt)	2003-08-22	2006-10-24	Avanir Pharmaceuticals	derivados de naftiridina substituìda como inibidores do fator inibidor da migração de macrófagos e seu uso no tratamento de doenças humanas
CA2557503A1 (en) *	2004-02-25	2005-09-09	The United States Of America, As Represented By The Department Of Vetera Ns Affairs	Methods for diagnosing and treating bladder cancer
SE0400886D0 (sv) *	2004-04-02	2004-04-02	Amersham Biosciences Ab	Process of purification
CA2573596A1 (en) *	2004-07-13	2006-01-19	Universite Laval	S100 protein inhibitors for treating leukemia
US7659087B2 (en)	2004-07-23	2010-02-09	Aspenbio Pharma, Inc.	Methods and devices for diagnosis of appendicitis
SG150497A1 (en) *	2004-07-23	2009-03-30	Aspenbio Pharma Inc	Methods and devices for diagnosis of appendicitis
US20060229314A1 (en) *	2005-03-24	2006-10-12	Jagadish Sircar	Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
GB0605689D0 (en) *	2006-03-21	2006-05-03	Novartis Ag	Organic compounds
US9605302B2 (en) *	2008-09-03	2017-03-28	Quantumdx Group Limited	Sensing strategies and methods for nucleic acid detection using biosensors
US10444124B2 (en)	2011-05-20	2019-10-15	Riken	Clarifying reagent for biological materials and use thereof
EP2748613B1 (en)	2011-10-07	2021-05-05	Baxalta GmbH	Oxmif as a diagnostic marker
US10626166B2 (en) *	2014-08-22	2020-04-21	Baxalta Incorporated	Detection of CHO-MIF contaminations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE230876C (no) *
US4322274A (en) *	1980-08-28	1982-03-30	Wilson Gregory B	Method of diagnosing cystic fibrosis patients and asymptomatic carrier of the cystic fibrosis gene
GB2125047B (en)	1982-08-09	1986-02-19	Ciba Geigy Ag	Yeast hybrid vectors and their use for the production of polypeptides
GB8318754D0 (en) *	1983-07-11	1983-08-10	Fagerhol M K F	Human proteins anti-sera test kits
JPS6041697A (ja) *	1983-08-15	1985-03-05	Asahi Chem Ind Co Ltd	活性蛋白質誘導体の新規合成法
DE3479520D1 (en)	1983-11-21	1989-09-28	Ciba Geigy Ag	Synthesis of tissue plasminogen activator(tpa) by yeast
PT79519B (en)	1983-11-21	1986-12-11	Ciba Geigy Ag	Process for preparing protease inhibitors based on egline compounds
JPH0672158B2 (ja)	1984-05-24	1994-09-14	チバ−ガイギ− アクチエンゲゼルシヤフト	精製されたヒトマクロファージ遊走阻止因子
GB8915414D0 (en) *	1989-07-05	1989-08-23	Ciba Geigy	Novel cytokines

1987
- 1987-09-28 EP EP87810561A patent/EP0263072B1/en not_active Expired - Lifetime
- 1987-09-28 DE DE3789413T patent/DE3789413T2/de not_active Expired - Fee Related
- 1987-09-28 ES ES87810561T patent/ES2052602T3/es not_active Expired - Lifetime
- 1987-09-30 FI FI874287A patent/FI874287A/fi not_active IP Right Cessation
- 1987-10-01 PT PT85849A patent/PT85849B/pt not_active IP Right Cessation
- 1987-10-02 NO NO874159A patent/NO874159L/no unknown
- 1987-10-02 IE IE264587A patent/IE61773B1/en not_active IP Right Cessation
- 1987-10-02 AU AU79309/87A patent/AU7930987A/en not_active Abandoned
- 1987-10-02 DK DK517787A patent/DK517787A/da not_active Application Discontinuation
1990
- 1990-11-21 US US07/617,485 patent/US5350687A/en not_active Expired - Fee Related
1995
- 1995-07-27 US US08/508,142 patent/US5702920A/en not_active Expired - Fee Related
1996
- 1996-12-18 JP JP8338746A patent/JPH09188698A/ja active Pending

Also Published As

Publication number	Publication date
AU7930987A (en)	1988-05-19
FI874287A0 (fi)	1987-09-30
DK517787D0 (da)	1987-10-02
EP0263072A3 (en)	1990-01-10
ES2052602T3 (es)	1994-07-16
DE3789413D1 (de)	1994-04-28
IE872645L (en)	1988-04-03
JPH09188698A (ja)	1997-07-22
EP0263072B1 (en)	1994-03-23
US5350687A (en)	1994-09-27
FI874287A (fi)	1988-04-04
DE3789413T2 (de)	1994-07-28
DK517787A (da)	1988-04-04
IE61773B1 (en)	1994-11-30
PT85849B (pt)	1990-07-31
PT85849A (en)	1987-11-01
NO874159D0 (no)	1987-10-02
EP0263072A2 (en)	1988-04-06
US5702920A (en)	1997-12-30

Publication	Publication Date	Title
NO874159L (no)	1988-04-05	Nye lymfokin-relaterte peptider.
NO894919D0 (no)	1989-12-07	Nye aminobenzoater.
NO864237D0 (no)	1986-10-23	Nye forbindelser.
FI873581A (fi)	1988-02-21	Fast stoedanordning.
NO872590D0 (no)	1987-06-19	Nye kompleksforbindelser.
NO881384L (no)	1988-10-03	Peptider.
NO885108L (no)	1989-05-18	Peptider.
NO862922D0 (no)	1986-07-21	Nye forbindelser.
NO892949D0 (no)	1989-07-18	Nye proteiner.
NO882886D0 (no)	1988-06-29	Nye forbindelser.
NO863638D0 (no)	1986-09-11	Oktapeptid.
NO894907D0 (no)	1989-12-07	Nye alfa-cyano-beta-oksopropionamider.
NO883818D0 (no)	1988-08-26	Nye forbindelser.
NO904319L (no)	1991-04-08	Nye forbindelser.
NO891403D0 (no)	1989-04-04	Nye forbindelser.
NO901032D0 (no)	1990-03-05	Nye forbindelser.
NO872386L (no)	1987-12-07	Peptider.
NO883021D0 (no)	1988-07-06	Nye peptider.
NO874091D0 (no)	1987-09-29	Nye trombolytiske proteiner.
NO912122L (no)	1990-01-23	Nye allylaminoetylazoler.
NO874734D0 (no)	1987-11-12	Nye peptidderivater.
NO921024D0 (no)	1992-03-17	Nye lymfokin-relaterte peptider
NO863078D0 (no)	1986-07-30	Nye cykloalifatiske ketoaminer.
NO883008L (no)	1988-07-05	Peptidforbindelser.
DK344887D0 (da)	1987-07-06	Nye peptider